Articles with public access mandates - Raphael MechoulamLearn more
Not available anywhere: 13
Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors
F Espejo-Porras, J Fernández-Ruiz, RG Pertwee, R Mechoulam, C García
Neuropharmacology 75, 155-163, 2013
Mandates: Government of Spain
Effect of prior foot shock stress and Δ9-tetrahydrocannabinol, cannabidiolic acid, and cannabidiol on anxiety-like responding in the light-dark emergence test in rats
EM Rock, CL Limebeer, GN Petrie, LA Williams, R Mechoulam, LA Parker
Psychopharmacology 234, 2207-2217, 2017
Mandates: Canadian Institutes of Health Research, Natural Sciences and Engineering …
Effects on sleep and dopamine levels of microdialysis perfusion of cannabidiol into the lateral hypothalamus of rats
E Murillo-Rodríguez, M Palomero-Rivero, D Millán-Aldaco, R Mechoulam, ...
Life sciences 88 (11-12), 504-511, 2011
Mandates: US National Institutes of Health
Omega-3 N-acylethanolamines are endogenously synthesised from omega-3 fatty acids in different human prostate and breast cancer cell lines
I Brown, KWJ Wahle, MG Cascio, R Smoum-Jaouni, R Mechoulam, ...
Prostaglandins, leukotrienes and essential fatty acids 85 (6), 305-310, 2011
Mandates: US National Institutes of Health
Organocatalytic electrochemical C–H lactonization of aromatic carboxylic acids
L Li, Q Yang, Z Jia, S Luo
Synthesis 50 (15), 2924-2929, 2018
Mandates: Chinese Academy of Sciences, National Natural Science Foundation of China
Evaluation of repeated or acute treatment with cannabidiol (CBD), cannabidiolic acid (CBDA) or CBDA methyl ester (HU-580) on nausea and/or vomiting in rats and shrews
EM Rock, MT Sullivan, SA Collins, H Goodman, CL Limebeer, ...
Psychopharmacology 237, 2621-2631, 2020
Mandates: Canadian Institutes of Health Research, Natural Sciences and Engineering …
CB1 cannabinoid receptors mediate endochondral skeletal growth attenuation by Δ9‐tetrahydrocannabinol
E Wasserman, J Tam, R Mechoulam, A Zimmer, G Maor, I Bab
Annals of the new York Academy of Sciences 1335 (1), 110-119, 2015
Mandates: German Research Foundation
Oleoyl alanine (HU595): a stable monomethylated oleoyl glycine interferes with acute naloxone precipitated morphine withdrawal in male rats
SM Ayoub, R Smoum, M Farag, H Atwal, SA Collins, EM Rock, ...
Psychopharmacology 237, 2753-2765, 2020
Mandates: Natural Sciences and Engineering Research Council of Canada
Oleoyl glycine: interference with the aversive effects of acute naloxone-precipitated MWD, but not morphine reward, in male Sprague–Dawley rats
GN Petrie, KL Wills, F Piscitelli, R Smoum, CL Limebeer, EM Rock, ...
Psychopharmacology 236, 2623-2633, 2019
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
Cannabinoid 2 (CB2) receptor agonism reduces lithium chloride-induced vomiting in Suncus murinus and nausea-induced conditioned gaping in rats
EM Rock, N Boulet, CL Limebeer, R Mechoulam, LA Parker
European Journal of Pharmacology 786, 94-99, 2016
Mandates: Natural Sciences and Engineering Research Council of Canada
Intraperirhinal cortex administration of the synthetic cannabinoid, HU210, disrupts object recognition memory in rats
MA Sticht, DL Jacklin, R Mechoulam, LA Parker, BD Winters
Neuroreport 26 (5), 258-262, 2015
Mandates: US National Institutes of Health
Effect of oleoyl glycine and oleoyl alanine on lithium chloride induced nausea in rats and vomiting in shrews
EM Rock, CL Limebeer, R Smoum, R Mechoulam, LA Parker
Psychopharmacology, 1-7, 2022
Mandates: Canadian Institutes of Health Research, Natural Sciences and Engineering …
Behavioral effects induced by the cannabidiol analogs HU-502 and HU-556
DAE Colodete, NR Silva, JFC Pedrazzi, MV Fogaça, I Cortez, EA Del-Bel, ...
Behavioural Pharmacology 34 (4), 213-224, 2023
Mandates: Fundação de Amparo à Pesquisa do Estado de São Paulo
Available somewhere: 57
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2
RG Pertwee, AC Howlett, ME Abood, SPH Alexander, V Di Marzo, ...
Pharmacological reviews 62 (4), 588-631, 2010
Mandates: US National Institutes of Health
The endocannabinoid system and the brain
R Mechoulam, LA Parker
Annual review of psychology 64 (1), 21-47, 2013
Mandates: US National Institutes of Health
Endocannabinoid signaling at the periphery: 50 years after THC
M Maccarrone, I Bab, T Bíró, GA Cabral, SK Dey, V Di Marzo, JC Konje, ...
Trends in pharmacological sciences 36 (5), 277-296, 2015
Mandates: US National Institutes of Health, Canadian Institutes of Health Research …
Peripheral cannabinoid receptor, CB2, regulates bone mass
O Ofek, M Karsak, N Leclerc, M Fogel, B Frenkel, K Wright, J Tam, ...
Proceedings of the National Academy of Sciences 103 (3), 696-701, 2006
Mandates: German Research Foundation
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
P Pacher, R Mechoulam
Progress in lipid research 50 (2), 193-211, 2011
Mandates: US National Institutes of Health
Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy
M Rajesh, P Mukhopadhyay, S Bátkai, V Patel, K Saito, S Matsumoto, ...
Journal of the American College of Cardiology 56 (25), 2115-2125, 2010
Mandates: US National Institutes of Health, Hungarian Scientific Research Fund
Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's disease
AM Martín-Moreno, D Reigada, BG Ramírez, R Mechoulam, N Innamorato, ...
Molecular pharmacology 79 (6), 964-973, 2011
Mandates: US National Institutes of Health, Government of Spain
Publication and funding information is determined automatically by a computer program